Global Long Acting Insulins Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long Acting Insulins Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Insulin Glargine
1.2.3 Insulin Determir
1.2.4 Insulin Degludec
1.2.5 Long Acting Animal Insulin
1.3 Market by Application
1.3.1 Global Long Acting Insulins Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Long Acting Insulins Market Perspective (2017-2028)
2.2 Long Acting Insulins Growth Trends by Region
2.2.1 Long Acting Insulins Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Long Acting Insulins Historic Market Size by Region (2017-2022)
2.2.3 Long Acting Insulins Forecasted Market Size by Region (2023-2028)
2.3 Long Acting Insulins Market Dynamics
2.3.1 Long Acting Insulins Industry Trends
2.3.2 Long Acting Insulins Market Drivers
2.3.3 Long Acting Insulins Market Challenges
2.3.4 Long Acting Insulins Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long Acting Insulins Players by Revenue
3.1.1 Global Top Long Acting Insulins Players by Revenue (2017-2022)
3.1.2 Global Long Acting Insulins Revenue Market Share by Players (2017-2022)
3.2 Global Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Long Acting Insulins Revenue
3.4 Global Long Acting Insulins Market Concentration Ratio
3.4.1 Global Long Acting Insulins Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long Acting Insulins Revenue in 2021
3.5 Long Acting Insulins Key Players Head office and Area Served
3.6 Key Players Long Acting Insulins Product Solution and Service
3.7 Date of Enter into Long Acting Insulins Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long Acting Insulins Breakdown Data by Type
4.1 Global Long Acting Insulins Historic Market Size by Type (2017-2022)
4.2 Global Long Acting Insulins Forecasted Market Size by Type (2023-2028)
5 Long Acting Insulins Breakdown Data by Application
5.1 Global Long Acting Insulins Historic Market Size by Application (2017-2022)
5.2 Global Long Acting Insulins Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Long Acting Insulins Market Size (2017-2028)
6.2 North America Long Acting Insulins Market Size by Country (2017-2022)
6.3 North America Long Acting Insulins Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Long Acting Insulins Market Size (2017-2028)
7.2 Europe Long Acting Insulins Market Size by Country (2017-2022)
7.3 Europe Long Acting Insulins Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long Acting Insulins Market Size (2017-2028)
8.2 Asia-Pacific Long Acting Insulins Market Size by Country (2017-2022)
8.3 Asia-Pacific Long Acting Insulins Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Long Acting Insulins Market Size (2017-2028)
9.2 Latin America Long Acting Insulins Market Size by Country (2017-2022)
9.3 Latin America Long Acting Insulins Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long Acting Insulins Market Size (2017-2028)
10.2 Middle East & Africa Long Acting Insulins Market Size by Country (2017-2022)
10.3 Middle East & Africa Long Acting Insulins Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Detail
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Long Acting Insulins Introduction
11.1.4 Novo Nordisk Revenue in Long Acting Insulins Business (2017-2022)
11.1.5 Novo Nordisk Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Long Acting Insulins Introduction
11.2.4 Sanofi Revenue in Long Acting Insulins Business (2017-2022)
11.2.5 Sanofi Recent Development
11.3 Wockhardt UK
11.3.1 Wockhardt UK Company Detail
11.3.2 Wockhardt UK Business Overview
11.3.3 Wockhardt UK Long Acting Insulins Introduction
11.3.4 Wockhardt UK Revenue in Long Acting Insulins Business (2017-2022)
11.3.5 Wockhardt UK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Long Acting Insulins Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Insulin Glargine
Table 3. Key Players of Insulin Determir
Table 4. Key Players of Insulin Degludec
Table 5. Key Players of Long Acting Animal Insulin
Table 6. Global Long Acting Insulins Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Long Acting Insulins Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Long Acting Insulins Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Long Acting Insulins Market Share by Region (2017-2022)
Table 10. Global Long Acting Insulins Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Long Acting Insulins Market Share by Region (2023-2028)
Table 12. Long Acting Insulins Market Trends
Table 13. Long Acting Insulins Market Drivers
Table 14. Long Acting Insulins Market Challenges
Table 15. Long Acting Insulins Market Restraints
Table 16. Global Long Acting Insulins Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Long Acting Insulins Market Share by Players (2017-2022)
Table 18. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Insulins as of 2021)
Table 19. Ranking of Global Top Long Acting Insulins Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Long Acting Insulins Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Long Acting Insulins Product Solution and Service
Table 23. Date of Enter into Long Acting Insulins Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Long Acting Insulins Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Long Acting Insulins Revenue Market Share by Type (2017-2022)
Table 27. Global Long Acting Insulins Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Long Acting Insulins Revenue Market Share by Type (2023-2028)
Table 29. Global Long Acting Insulins Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Long Acting Insulins Revenue Market Share by Application (2017-2022)
Table 31. Global Long Acting Insulins Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Long Acting Insulins Revenue Market Share by Application (2023-2028)
Table 33. North America Long Acting Insulins Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Long Acting Insulins Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Long Acting Insulins Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Long Acting Insulins Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Long Acting Insulins Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Long Acting Insulins Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Long Acting Insulins Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Long Acting Insulins Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Long Acting Insulins Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Long Acting Insulins Market Size by Country (2023-2028) & (US$ Million)
Table 43. Novo Nordisk Company Detail
Table 44. Novo Nordisk Business Overview
Table 45. Novo Nordisk Long Acting Insulins Product
Table 46. Novo Nordisk Revenue in Long Acting Insulins Business (2017-2022) & (US$ Million)
Table 47. Novo Nordisk Recent Development
Table 48. Sanofi Company Detail
Table 49. Sanofi Business Overview
Table 50. Sanofi Long Acting Insulins Product
Table 51. Sanofi Revenue in Long Acting Insulins Business (2017-2022) & (US$ Million)
Table 52. Sanofi Recent Development
Table 53. Wockhardt UK Company Detail
Table 54. Wockhardt UK Business Overview
Table 55. Wockhardt UK Long Acting Insulins Product
Table 56. Wockhardt UK Revenue in Long Acting Insulins Business (2017-2022) & (US$ Million)
Table 57. Wockhardt UK Recent Development
Table 58. Research Programs/Design for This Report
Table 59. Key Data Information from Secondary Sources
Table 60. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Long Acting Insulins Market Share by Type: 2021 VS 2028
Figure 2. Insulin Glargine Features
Figure 3. Insulin Determir Features
Figure 4. Insulin Degludec Features
Figure 5. Long Acting Animal Insulin Features
Figure 6. Global Long Acting Insulins Market Share by Application in 2021 & 2028
Figure 7. Home Use Case Studies
Figure 8. Medical Institutions Case Studies
Figure 9. Others Case Studies
Figure 10. Long Acting Insulins Report Years Considered
Figure 11. Global Long Acting Insulins Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Long Acting Insulins Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Long Acting Insulins Market Share by Region: 2021 VS 2028
Figure 14. Global Long Acting Insulins Market Share by Players in 2021
Figure 15. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long Acting Insulins as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Long Acting Insulins Revenue in 2021
Figure 17. North America Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Long Acting Insulins Market Share by Country (2017-2028)
Figure 19. United States Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Long Acting Insulins Market Share by Country (2017-2028)
Figure 23. Germany Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Long Acting Insulins Market Share by Region (2017-2028)
Figure 31. China Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Long Acting Insulins Market Share by Country (2017-2028)
Figure 39. Mexico Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Long Acting Insulins Market Share by Country (2017-2028)
Figure 43. Turkey Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Long Acting Insulins Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Novo Nordisk Revenue Growth Rate in Long Acting Insulins Business (2017-2022)
Figure 46. Sanofi Revenue Growth Rate in Long Acting Insulins Business (2017-2022)
Figure 47. Wockhardt UK Revenue Growth Rate in Long Acting Insulins Business (2017-2022)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed